V

Vertex Ventures HC

9 employees

Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health.

Investor insights

Sectors invested in

Biotechnology26
Health Care24
Therapeutics13
Medical Device11
Medical10
Life Science8
Pharmaceutical8
Biopharma5
Health Diagnostics4
hearing loss3
World's first contact hearing solution3
innovation3
The Earlens Difference3
hearing aid3
Information Technology3
Clinical Trials3
Developer Platform2
Medical Devices2
Sports medicine2
Joint Unloading2

Funding rounds participated in

$420K sweet spot round size

Most of their 35 investments are in rounds between $33M and $85M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Medical Device
Financial Services
Health Care
Finance
Pharmaceutical

Date founded

2014

Investments made

S

Septerna raised $150M on July 11, 2023

Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, Woodline Partners LP, RA Capital Management, L.P., Soleus Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP and Vertex Ventures HC

S

SpyGlass Pharma, Inc. raised $90M on July 10, 2023

Investors: Vensana Capital, Samsara BioCapital, RA Capital Management, L.P. and Vertex Ventures HC

B

Boundless Bio raised $100M on May 16, 2023

Investors: Nextech Invest, Sectoral Asset Management, Partner Fund Management, Redmile Group, Leaps by Bayer, Surveyor Capital, Logos Global Management, LP, RA Capital Management, L.P., Wellington Management and Vertex Ventures HC

U

Undisclosed raised $158M on April 13, 2023

Investors: Goldman Sachs Asset Management, Bristol-Myers Squibb, UK, OCV and Vertex Ventures HC

S

SonoThera raised $61M on December 5, 2022

Investors: Formic Ventures, Medical Excellence Capital, LLC, Illumina Ventures, Foothill Ventures, ARCH Venture Partners, Wilson Sonsini Goodrich & Rosati and Vertex Ventures HC

M

Matchpoint Therapeutics raised $70M on October 14, 2022

Investors: Sanofi Ventures, Digitalis Ventures and Vertex Ventures HC

A

Allay Therapeutics raised $60M on September 15, 2021

Investors: Vertex Growth, Temasek, Brandon Capital Partners and Vertex Ventures HC

O

Obsidian Therapeutics raised $115M on September 9, 2021

Investors: RA Capital Management, L.P., Logos Global Management, LP, Samsara BioCapital, Surveyor Capital, Soleus Capital Management, L.P., The Column Group and Vertex Ventures HC

S

Sonoma Biotherapeutics raised $265M on August 4, 2021

Investors: NS Investment, Lilly Asia Ventures, Octagon Capital, Piper Sandler, JDRF T1D Fund, Osage University Partners (OUP), Lifeforce Capital, Mirae Asset MAPS Global Investments Co., Ltd and Vertex Ventures HC

N

Neuspera Medical Inc. raised $65M on July 20, 2021

Investors: Treo Ventures, Windham Venture Partners and Vertex Ventures HC

FAQ